Regorafenib, Ipilimumab and Nivolumab in Microsatellite-Solid Metastatic Colorectal Most cancers

via Matthew Stanger Posted: 3/15/2023 9:06:00 am Ultimate Replace: 3/15/2023 8:47:20 am Reported in a single-institution section I trial JAMA Oncology, Marwan Fakih, MDand associates discovered {that a} mixture of regorafenib, ipilimumab, and nivolumab confirmed proof of job in sufferers with microsatellite-stable metastatic colorectal most cancers who didn’t have liver metastases. find out about main … Read more